Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China

Overview of attention for article published in Clinical Drug Investigation, January 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 63 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 12,566 followers.

Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China. https://t.co/anMxinKN65

Reply Repost Favourite